Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis

Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis

Abstract Background Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been increasingly used over the last decade in patients with refractory cardiogenic shock. ECMO weaning can, however, be challenging and lead to circulatory failure and death. Recent data suggest a potential benefit...

Full description

Bibliographic Details
Main Authors: Enrique Guilherme, Matthias Jacquet-Lagrèze, Matteo Pozzi, Felix Achana, Xavier Armoiry, Jean-Luc Fellahi
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Critical Care
Subjects:
Levosimendan
VA-ECMO
Cardiogenic shock
ECMO weaning failure
Circulatory failure
Online Access:http://link.springer.com/article/10.1186/s13054-020-03122-y

Internet

http://link.springer.com/article/10.1186/s13054-020-03122-y

Similar Items